Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Perceptions of Artificial Intelligence Among Pulmonologists
0
Zitationen
2
Autoren
2025
Jahr
Abstract
<title>Extract</title> Artificial intelligence (AI) applications are being increasingly deployed within medical specialties, including pulmonology [1]. An early role for these applications within pulmonology lies in lung nodule management [2]. This is especially important for interventional pulmonologists (IP) and advanced diagnostic bronchoscopists (ADB). There are an estimated 1.6 million lung nodules identified annually in the United States, and management remains a challenge [3]. Thus, there is an increasing relevance of AI applications that aid in lung nodule detection, tracking, and risk characterization. Also, experimental reports have demonstrated autonomous medical needle steering in-vivo in animals <italic>i.e.</italic> AI-aided navigational bronchoscopy [4]. As the adoption of AI increases in pulmonology, it is essential that healthcare professionals (HCPs) are familiar with AI-related terms, technologies, and their advantages and disadvantages. Accordingly, a survey was conducted to assess the perspectives of IP and ADB HCPs regarding the integration of AI into their clinical practice.
Ähnliche Arbeiten
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 · 15.793 Zit.
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 · 11.470 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.863 Zit.
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 · 9.981 Zit.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
2015 · 9.414 Zit.